↑Nakamura M, Kondo H, Mori T; et al. (2007). "Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis". Hepatology. 45 (1): 118–27. doi:10.1002/hep.21472. PMID17187436.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)